Tobramycin sulfate/vancomycin hydrochloride (Osteal Therapeutics)

硫酸妥布霉素/盐酸万古霉素 (Osteal Therapeutics)

Report date: 2024/08/14 10:48:58

Base Information

Drug NameTobramycin sulfate/vancomycin hydrochloride (Osteal Therapeutics)
Drug Alias NameVT-X7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitorsCell wall inhibitorsPeptidoglycan inhibitors
Targets30S ribosomal subunitPeptidoglycan
Therapy Area/IndicationsProsthesis-Related InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Tobramycin SulfateVancomycin Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOsteal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOsteal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProsthesis-Related InfectionsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A